Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers

The use of fluorescently labeled major histocompatibility complex multimers has become an essential technique for analyzing disease- and therapy-induced T-cell immunity. Whereas classical major histocompatibility complex multimer analyses are well-suited for the detection of immune responses to a few epitopes, limitations on human-subject sample size preclude a comprehensive analysis of T-cell immunity. To address this issue, we developed a combinatorial encoding strategy that allows the parallel detection of a multitude of different T-cell populations in a single sample. Detection of T cells from peripheral blood by combinatorial encoding is as efficient as detection with conventionally labeled multimers but results in a substantially increased sensitivity and, most notably, allows comprehensive screens to be performed. We obtained proof of principle for the feasibility of large-scale screening of human material by analysis of human leukocyte antigen A3–restricted T-cell responses to known and potential melanoma-associated antigens in peripheral blood from individuals with melanoma.

[1]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[2]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[3]  T. Schumacher,et al.  MHC multimer technology: current status and future prospects. , 2005, Current opinion in immunology.

[4]  H. Ploegh,et al.  The CD8 T-Cell Response against Murine Gammaherpesvirus 68 Is Directed toward a Broad Repertoire of Epitopes from both Early and Late Antigens , 2008, Journal of Virology.

[5]  Carl Wood,et al.  Current Status and Future Prospects , 1984 .

[6]  V. Appay,et al.  Phenotype and function of human T lymphocyte subsets: Consensus and issues , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[7]  A. Casrouge,et al.  A Direct Estimate of the Human αβ T Cell Receptor Diversity , 1999 .

[8]  A. Sette,et al.  Identification of GP100‐derived, melanoma‐specific cytotoxic T‐lymphocyte epitopes restricted by HLA‐A3 supertype molecules by primary in vitro immunization with peptide‐pulsed dendritic cells , 1998, International journal of cancer.

[9]  H. Ploegh,et al.  Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. , 2008, The Journal of infectious diseases.

[10]  D. Price,et al.  Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry , 2006, Nature Medicine.

[11]  T. Schumacher,et al.  Selective Expansion of Cross-Reactive Cd8+ Memory T Cells by Viral Variants , 1999, The Journal of experimental medicine.

[12]  T. Schumacher,et al.  On the Role of Melanoma-Specific CD8+ T-Cell Immunity in Disease Progression of Advanced-Stage Melanoma Patients , 2004, Clinical Cancer Research.

[13]  K Ann McKibbon,et al.  Current status and future prospects. , 2008, Health information and libraries journal.

[14]  T. Schumacher,et al.  Design and use of conditional MHC class I ligands , 2006, Nature Medicine.

[15]  K. Sakaguchi,et al.  Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. , 1998, Journal of immunology.

[16]  Hidde L. Ploegh,et al.  Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers , 2008, Proceedings of the National Academy of Sciences.

[17]  D. Wiley,et al.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Casrouge,et al.  A direct estimate of the human alphabeta T cell receptor diversity. , 1999, Science.

[19]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[20]  T. Schumacher,et al.  Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 , 2008, Proceedings of the National Academy of Sciences.

[21]  D. Hunt,et al.  Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. , 1996, Journal of immunology.

[22]  T. Schumacher,et al.  Generation of peptide–MHC class I complexes through UV-mediated ligand exchange , 2006, Nature Protocols.